Comparison of Patient Susceptibility Genes Across Breast Cancer: Implications for Prognosis and Therapeutic Outcomes.

Peleg Hasson, Shira; Menes, Tehillah; Sonnenblick, Amir

Peleg Hasson, Shira; Menes, Tehillah; Sonnenblick, Amir.

Afiliación

Peleg Hasson S; Oncology Department, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Menes T; Department of Surgery, Tel Aviv-Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Sonnenblick A; Oncology Department, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Pharmgenomics Pers Med ; 13: 227-238, 2020.

Article en En | MEDLINE | ID: mdl-32801835

Palabras clave

BRCA; CDH1; Lynch syndrome; PTEN; TP53; breast cancer

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: Pharmgenomics Pers Med Año: 2020 Tipo del documento: Article País de afiliación: Israel

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google